DK45986A - Fremgangsmaade til behandling af farmaceutiske dosisformer - Google Patents

Fremgangsmaade til behandling af farmaceutiske dosisformer Download PDF

Info

Publication number
DK45986A
DK45986A DK45986A DK45986A DK45986A DK 45986 A DK45986 A DK 45986A DK 45986 A DK45986 A DK 45986A DK 45986 A DK45986 A DK 45986A DK 45986 A DK45986 A DK 45986A
Authority
DK
Denmark
Prior art keywords
dosage forms
pharmaceutical dosage
treating pharmaceutical
treating
forms
Prior art date
Application number
DK45986A
Other languages
Danish (da)
English (en)
Other versions
DK45986D0 (da
Inventor
Isaac Ghebre-Sellassie
Robert H Gordon
Michael R Harris
Jr Russell U Nesbitt
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK45986D0 publication Critical patent/DK45986D0/da
Publication of DK45986A publication Critical patent/DK45986A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK45986A 1985-01-31 1986-01-30 Fremgangsmaade til behandling af farmaceutiske dosisformer DK45986A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/696,955 US4600645A (en) 1985-01-31 1985-01-31 Process for treating dosage forms

Publications (2)

Publication Number Publication Date
DK45986D0 DK45986D0 (da) 1986-01-30
DK45986A true DK45986A (da) 1986-08-01

Family

ID=24799186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK45986A DK45986A (da) 1985-01-31 1986-01-30 Fremgangsmaade til behandling af farmaceutiske dosisformer

Country Status (17)

Country Link
US (1) US4600645A (de)
JP (1) JPS61176521A (de)
AU (1) AU583582B2 (de)
BE (1) BE904136A (de)
CA (1) CA1270760A (de)
CH (1) CH667008A5 (de)
DE (1) DE3601001A1 (de)
DK (1) DK45986A (de)
ES (1) ES8802371A1 (de)
FR (1) FR2576786B1 (de)
IT (1) IT1190466B (de)
LU (1) LU86274A1 (de)
NL (1) NL8600194A (de)
NZ (1) NZ214983A (de)
PH (1) PH22751A (de)
SE (1) SE8600402L (de)
ZA (1) ZA86276B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
WO1987006098A1 (en) * 1986-04-07 1987-10-22 Rorer International (Overseas) Inc. Method for the preparation of a sustained release pharmaceutical composition and the composition prepared thereby
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
JPH0774166B2 (ja) * 1987-02-06 1995-08-09 信越化学工業株式会社 徐放性被覆薬剤の製造方法
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
US5068110A (en) * 1987-09-29 1991-11-26 Warner-Lambert Company Stabilization of enteric coated dosage form
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5025004A (en) * 1988-06-13 1991-06-18 Eastman Kodak Company Water-dispersible polymeric compositions
US4960814A (en) * 1988-06-13 1990-10-02 Eastman Kodak Company Water-dispersible polymeric compositions
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5286493A (en) * 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US5789014A (en) * 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
AU4219497A (en) * 1996-09-13 1998-04-02 Shionogi & Co., Ltd. Sustained-release preparation utilizing thermal change and process for the production thereof
CA2270975C (en) 1997-07-02 2003-04-01 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
KR100960200B1 (ko) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
EP1526843A1 (de) * 2002-07-25 2005-05-04 Pharmacia Corporation Verfahren zur herstellung fester dosierformen mit einem zweischichtigen überzug aus einem wasserunlöslichen polymer und einem wasserlöslichen porenbildner
JP4767492B2 (ja) * 2003-12-25 2011-09-07 ライオン株式会社 高分子被覆粒子の製造方法、高分子被覆粒子、並びにこれを用いた圧縮成形品
JP2009526096A (ja) * 2006-02-07 2009-07-16 エフ エム シー コーポレーション 徐放性被覆をつくるためのコーティング方法
BRPI0709606B8 (pt) 2006-03-16 2021-05-25 Tris Pharma Inc suspensão líquida administrável oralmente com características de liberação modificada
US20080069871A1 (en) * 2006-07-21 2008-03-20 Vaughn Jason M Hydrophobic abuse deterrent delivery system
US20100068233A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Modifiable dosage form
US20100068152A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable particle or polymeric based final dosage form
US20100068266A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo-modifiable multiple-release state final dosage form
US20100069821A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable medicament release-sites final dosage form
US20100069887A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multiple chamber ex vivo adjustable-release final dosage form
US20100068235A1 (en) * 2008-09-16 2010-03-18 Searete LLC, a limited liability corporation of Deleware Individualizable dosage form
US20100068153A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo activatable final dosage form
US20100068254A1 (en) * 2008-09-16 2010-03-18 Mahalaxmi Gita Bangera Modifying a medicament availability state of a final dosage form
US20100068275A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Personalizable dosage form
EP2726066B1 (de) * 2011-06-28 2021-03-31 Neos Therapeutics, LP Dosisformen für amphetamin zur oralen verabreichung
EP2790729A4 (de) 2011-12-12 2015-08-12 Orbis Biosciences Inc Partikelformulierungen mit verzögerter freisetzung
AU2013302657B2 (en) 2012-08-15 2018-08-09 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173839A (en) * 1962-01-09 1965-03-16 Smith Kline French Lab Method of printing pharmaceutical forms
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
DE2522483C2 (de) * 1975-05-21 1984-06-28 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von lackierten Tabletten
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS5855125B2 (ja) * 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli

Also Published As

Publication number Publication date
IT1190466B (it) 1988-02-16
BE904136A (fr) 1986-07-29
US4600645A (en) 1986-07-15
SE8600402L (sv) 1986-08-01
FR2576786B1 (fr) 1989-05-26
SE8600402D0 (sv) 1986-01-30
DE3601001A1 (de) 1986-08-07
NL8600194A (nl) 1986-08-18
CH667008A5 (fr) 1988-09-15
JPS61176521A (ja) 1986-08-08
PH22751A (en) 1988-11-28
ES8802371A1 (es) 1988-05-16
NZ214983A (en) 1988-02-29
DK45986D0 (da) 1986-01-30
AU5261986A (en) 1986-08-07
LU86274A1 (fr) 1986-06-09
FR2576786A1 (fr) 1986-08-08
ES551441A0 (es) 1988-05-16
ZA86276B (en) 1986-08-27
IT8647603A0 (it) 1986-01-30
CA1270760A (en) 1990-06-26
AU583582B2 (en) 1989-05-04

Similar Documents

Publication Publication Date Title
DK45986A (da) Fremgangsmaade til behandling af farmaceutiske dosisformer
DK99086A (da) Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser
DK545088A (da) Doseringsform til behandling af kardiovaskulaere sygdomme
DK376087D0 (da) Behandling af emulsioner
DK618387D0 (da) Fremgangsmaade til sterilisering
NO172928C (no) Fremgangsmaate for vaeskebehandling
DK222986A (da) Praeparat til behandling af diarre
DK165355C (da) Fremgangsmaade til mikroindkapsling af laegemidler
DK550586D0 (da) Laegemiddel til behandling af neuropsykiatriske tilstande, saasom demens
DE3585722D1 (de) Geraet zur iontophoretischen verabreichung von medikamenten.
DK133786A (da) Praeparat til tandbehandling
DK162121C (da) Fremgangsmaade til behandling af affaldsprodukter
DK165250C (da) Fremgangsmaade til fremstilling af 2-amino-6-chlorpurin
DK162752C (da) Fremgangsmaade til overfladebehandling af folier
DK298187A (da) Applikator til behandling af laeber
DK462886A (da) Algedraebende midler til behandling af vandsystemer
DK4786A (da) Fremgangsmaade til behandling af biomasse
DK36984D0 (da) Apparat til behandling af ar
DK453586D0 (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid
KR870700350A (ko) 간염의 치료방법
DK343686D0 (da) Paafoeringsindretning til paafoering af neglelak
RO92640A2 (ro) Metoda pentru tratamentul keratitelor virotice
DK510785D0 (da) Oploesning til behandling af taender
DK461983D0 (da) Fremgangsmade til intravenoes dosering af medikamenter
RO91766A2 (ro) Metoda de tratament a enterobiozei

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment